Quick Answer
Enveric Biosciences, Inc. reported Shares Outstanding of 1.06 million shares for fiscal year 2025.
Enveric Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.06M | +1778.8% |
| 2024 | 56,501 | -69.1% |
| 2023 | 182,625 | -91.2% |
| 2022 | 2.08M | +218.8% |
| 2021 | 651,921 | -93.5% |
| 2020 | 10.10M | +90.1% |
| 2019 | 5.31M | +213.7% |
| 2018 | 1.69M | -90.7% |
| 2017 | 18.16M | +30.8% |
| 2016 | 13.89M | -9.9% |
| 2014 | 15.41M | +26.9% |
| 2013 | 12.14M | +0.0% |
| 2012 | 12.14M | +0.0% |
| 2011 | 12.14M | +86.8% |
| 2010 | 6.50M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 518,296 | -94.2% | -82.9% |
| June 30, 2025 | 3.03M | -61.6% | +22.4% |
| March 31, 2025 | 2.47M | -66.1% | +16477606.7% |
| January 31, 2025 | 15 | — | -100.0% |
| December 31, 2024 | 56,501 | -97.9% | -99.4% |
| September 30, 2024 | 8.99M | +312.2% | +14.2% |
| June 30, 2024 | 7.88M | +267.9% | +8.0% |
| March 31, 2024 | 7.29M | +251.0% | +166.3% |
- Enveric Biosciences, Inc. showed an increase of +1778.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Enveric Biosciences, Inc.’s shares outstanding has declined by 83.7% (from 6.50 million shares to 1.06 million shares).
- The most recent figure is from Enveric Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: